The morphometric prognostic index is the strongest prognosticator in premenopausal lymph node-negative and lymph node-positive breast cancer patients
- 1 April 1991
- journal article
- Published by Elsevier in Human Pathology
- Vol. 22 (4), 326-330
- https://doi.org/10.1016/0046-8177(91)90080-9
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast‐cancer patients with long follow‐upInternational Journal of Cancer, 1990
- Relation of tumor size, lymph node status, and survival in 24,740 breast cancer casesCancer, 1989
- The multivariate prognostic index and nuclear DNA content are independent prognostic factors in primary breast cancer patientsCytometry, 1989
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerNew England Journal of Medicine, 1988
- Comparison of extent of disease and morphometric and DNA flow cytometric prognostic factors in invasive ductal breast cancer.Journal of Clinical Pathology, 1987
- Consensus conference. Adjuvant chemotherapy for breast cancerPublished by American Medical Association (AMA) ,1985
- The value of morphometry to classic prognosticators in breast cancerCancer, 1985
- Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancerBreast Cancer Research and Treatment, 1985
- ADJUVANT CMF CHEMOTHERAPY IN OPERABLE BREAST CANCER: TEN YEARS LATERThe Lancet, 1985
- Management and survival of female breast cancer: Results of a national survey by the American college of surgeonsCancer, 1980